Hematology
There is no content available at this time. Please check again later.
Relevant Content
Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy
What is VTE: Why Does it Matter?
Researchers at Heart
Health Care Affordability in the United States, From Crisis to Action
Polypharmacy is common in cardiovascular (CV) care because guideline-direc...
Transforming VTE Care: From Risk Identification to Protocol Implementation
U.S. health care costs exceed $5T yearly, driving delayed care and debt. E...
DanGers of Delays in Cardiogenic Shock: Benefit Persists But Attenuates
Circulation: Cardiovascular Interventions, Ahead of Print.
2026 Heart Disease and Stroke Statistics
AHA and NIH’s 2026 Statistics Update delivers the latest U.S. data on hear...
Pragmatic Approaches to the Evaluation and Monitoring of Artificial Intelligence in Healthcare
AHA advisory outlines risk-based governance and continuous monitoring for...
Implications of HFpEF Definitions Unveiled by Rest and Exercise Hemodynamics
Circulation Research, Ahead of Print.
Sex Differences in the Neurovascular Health of Aging Adults
Stroke, Ahead of Print.
BACKGROUND:Poor cerebrovascular reactivity is...
BACKGROUND:Poor cerebrovascular reactivity is...
